CO4700303A1 - Vacuna viva recombinante aviaria que utiliza como vector el virus de la laringotraqueitis infecciosa aviaria - Google Patents
Vacuna viva recombinante aviaria que utiliza como vector el virus de la laringotraqueitis infecciosa aviariaInfo
- Publication number
- CO4700303A1 CO4700303A1 CO97036155A CO97036155A CO4700303A1 CO 4700303 A1 CO4700303 A1 CO 4700303A1 CO 97036155 A CO97036155 A CO 97036155A CO 97036155 A CO97036155 A CO 97036155A CO 4700303 A1 CO4700303 A1 CO 4700303A1
- Authority
- CO
- Colombia
- Prior art keywords
- aviary
- virus
- living
- recombinant vaccine
- infectious laryngotracheitis
- Prior art date
Links
- 108010008038 Synthetic Vaccines Proteins 0.000 title 1
- 206010044302 Tracheitis Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- 201000009837 laryngotracheitis Diseases 0.000 title 1
- 229940124551 recombinant vaccine Drugs 0.000 title 1
- 241000701063 Gallid alphaherpesvirus 1 Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000006798 recombination Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9608243A FR2750866B1 (fr) | 1996-06-27 | 1996-06-27 | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4700303A1 true CO4700303A1 (es) | 1998-12-29 |
Family
ID=9493649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97036155A CO4700303A1 (es) | 1996-06-27 | 1997-06-27 | Vacuna viva recombinante aviaria que utiliza como vector el virus de la laringotraqueitis infecciosa aviaria |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6153199A (https=) |
| EP (1) | EP0914458A1 (https=) |
| JP (1) | JP2000512844A (https=) |
| AR (1) | AR008620A1 (https=) |
| AU (1) | AU739374B2 (https=) |
| CO (1) | CO4700303A1 (https=) |
| FR (1) | FR2750866B1 (https=) |
| ID (1) | ID18351A (https=) |
| MA (1) | MA24222A1 (https=) |
| PE (1) | PE52599A1 (https=) |
| TN (1) | TNSN97109A1 (https=) |
| WO (1) | WO1997049826A1 (https=) |
| ZA (1) | ZA975618B (https=) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6913751B2 (en) | 1992-06-12 | 2005-07-05 | Schering-Plough Veterinary Corporation | Recombinant avian herpesvirus useful in vaccine production |
| DE69836557T2 (de) * | 1997-10-03 | 2007-09-20 | Zeon Corp. | Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden |
| AR031405A1 (es) * | 2000-11-21 | 2003-09-24 | Wyeth Corp | Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo |
| JP2002356441A (ja) * | 2001-03-15 | 2002-12-13 | Akzo Nobel Nv | 組換え伝染性喉頭気管炎ウイルスワクチン |
| US7314715B2 (en) * | 2001-06-14 | 2008-01-01 | Schering-Plough Animal Health Corporation | Recombinant avian herpesvirus useful in vaccine production |
| EP2022799A2 (en) | 2001-11-16 | 2009-02-11 | Biogen Idec Inc. | Polycistronic expression of antibodies |
| US20030157641A1 (en) * | 2001-11-16 | 2003-08-21 | Idec Pharmaceuticals Corporation | Polycistronic expression of antibodies |
| EP1606419A1 (en) | 2003-03-18 | 2005-12-21 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
| US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
| US20050214316A1 (en) | 2003-11-13 | 2005-09-29 | Brown Thomas P | Methods of characterizing infectious bursal disease virus |
| MXPA06009452A (es) | 2004-02-19 | 2007-03-15 | Univ Alberta | Polimorfismos del promotor de leptin y sus usos. |
| PT1881845E (pt) | 2005-04-25 | 2010-05-31 | Merial Ltd | Vacinas de vírus nipah |
| US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
| US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
| EP3147296A1 (en) | 2005-11-14 | 2017-03-29 | Merial, Inc. | Gene therapy for renal failure |
| US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
| WO2010115133A2 (en) | 2009-04-03 | 2010-10-07 | Merial Limited | Newcastle disease virus vectored avian vaccines |
| ES2380289T3 (es) | 2009-11-30 | 2012-05-10 | United Cancer Research Institute | Nuevo clon del virus de la enfermedad de Newcastle, su fabricación y aplicación en el tratamiento médico del cáncer |
| CN103260643A (zh) | 2009-12-28 | 2013-08-21 | 梅里亚有限公司 | 重组ndv抗原及其用途 |
| WO2012018813A2 (en) * | 2010-08-02 | 2012-02-09 | University Of Georgia Research Foundation, Inc. | Modified infectious laryngotracheitis virus (iltv) and uses thereof |
| WO2012030720A1 (en) | 2010-08-31 | 2012-03-08 | Merial Limited | Newcastle disease virus vectored herpesvirus vaccines |
| WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
| EP2694678A2 (en) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment |
| US20140296248A1 (en) | 2011-04-04 | 2014-10-02 | Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
| US9216213B2 (en) | 2011-04-20 | 2015-12-22 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
| HK1200329A1 (en) | 2011-04-25 | 2015-08-07 | 先进生物学实验室股份有限公司 | Truncated hiv envelope proteins (env), methods and compositions related thereto |
| CA2837375C (en) | 2011-06-01 | 2019-07-16 | Merial Limited | Needle-free administration of prrsv vaccines |
| SI2741740T1 (sl) | 2011-08-12 | 2017-08-31 | Merial, Inc. | Vakuumsko konzerviranje bioloških proizvodov, zlasti cepiv |
| WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
| WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
| WO2014081958A1 (en) | 2012-11-21 | 2014-05-30 | Cardiomems, Inc. | Devices, systems, and methods for pulmonary arterial hypertension (pah) assessment and treatment |
| WO2014164697A1 (en) | 2013-03-12 | 2014-10-09 | Merial Limited | Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof |
| US9198908B2 (en) | 2013-03-15 | 2015-12-01 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux Ii”) | Methods for the treatment of cardiovascular conditions |
| EP2845904A1 (en) * | 2013-09-06 | 2015-03-11 | Ceva Sante Animale | Recombinant Marek's disease viruses and uses thereof |
| CA2966191A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
| DK3313864T3 (da) | 2015-06-23 | 2021-11-01 | Boehringer Ingelheim Animal Health Usa Inc | Rekombinante virusvektorer indeholdende prrsv minor protein og fremgangsmåder til fremstilling og anvendelse deraf |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU629248B2 (en) * | 1988-09-13 | 1992-10-01 | Merial | Viral vaccines |
| WO1992003554A1 (en) * | 1990-08-24 | 1992-03-05 | Arthur Webster Pty. Ltd. | Infectious laryngotracheitis virus vaccine |
| WO1993025655A1 (en) * | 1992-06-12 | 1993-12-23 | Genencor International, Inc. | Enzymatic compositions and methods for producing stonewashed look on indigo-dyed denim fabric |
| AU2946395A (en) * | 1994-06-30 | 1996-01-25 | Board of Regents of the University of Illinois, The | Recombinant infectious laryngotracheitis virus and vaccine |
| FR2728794B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
| CA2216139C (en) * | 1995-03-23 | 2013-01-08 | Syntro Corporation | Recombinant infectious laryngotracheitis virus and uses thereof |
-
1996
- 1996-06-27 FR FR9608243A patent/FR2750866B1/fr not_active Expired - Lifetime
-
1997
- 1997-06-23 MA MA24675A patent/MA24222A1/fr unknown
- 1997-06-25 WO PCT/FR1997/001138 patent/WO1997049826A1/fr not_active Ceased
- 1997-06-25 AR ARP970102799A patent/AR008620A1/es unknown
- 1997-06-25 EP EP97930591A patent/EP0914458A1/fr not_active Withdrawn
- 1997-06-25 AU AU34487/97A patent/AU739374B2/en not_active Expired
- 1997-06-25 ZA ZA975618A patent/ZA975618B/xx unknown
- 1997-06-25 TN TNTNSN97109A patent/TNSN97109A1/fr unknown
- 1997-06-25 JP JP10502456A patent/JP2000512844A/ja active Pending
- 1997-06-26 ID IDP972222A patent/ID18351A/id unknown
- 1997-06-27 PE PE1997000548A patent/PE52599A1/es not_active Application Discontinuation
- 1997-06-27 CO CO97036155A patent/CO4700303A1/es unknown
-
1998
- 1998-12-23 US US09/219,932 patent/US6153199A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR2750866B1 (fr) | 1998-11-27 |
| TNSN97109A1 (fr) | 2005-03-15 |
| ID18351A (id) | 1998-04-02 |
| US6153199A (en) | 2000-11-28 |
| ZA975618B (en) | 1998-12-28 |
| JP2000512844A (ja) | 2000-10-03 |
| EP0914458A1 (fr) | 1999-05-12 |
| AR008620A1 (es) | 2000-02-09 |
| AU3448797A (en) | 1998-01-14 |
| AU739374B2 (en) | 2001-10-11 |
| MA24222A1 (fr) | 1997-12-31 |
| PE52599A1 (es) | 1999-07-16 |
| FR2750866A1 (fr) | 1998-01-16 |
| WO1997049826A1 (fr) | 1997-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4700303A1 (es) | Vacuna viva recombinante aviaria que utiliza como vector el virus de la laringotraqueitis infecciosa aviaria | |
| CO4650230A1 (es) | Vacuna viva recombinante aviaria, utilizando como vector el virus de la laringotraqueitis infecciosa aviaria | |
| CO4650231A1 (es) | Vacuna viva recombinante aviaria que utiliza como vector el virus de laringotraqueitis infecciosa aviaria | |
| DE69632235D1 (de) | Newcastle-Krankheitsvirus-Kombinationsimpfstoff | |
| BR0316758A (pt) | Vacinas baseadas em levedura como imunoterapia | |
| AR020134A1 (es) | Antigenos inmunologicos contra el virus herpes simplex y metodos para el uso de los mismos | |
| ES2143507T3 (es) | Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia. | |
| ES2069435T4 (es) | Composicion de vacuna para vacunar animales, en concreto mamiferos y mas concretamente cerdos o cochinos. | |
| AR011216A1 (es) | Una vacuna a base de antigenos superficiales contra la gripe, un metodo para prepararla y un metodo para la preparacion de proteinas antigenicas superficiales a partir de virus de gripe propagados sobre un cultivo celular animal | |
| DE60012711D1 (de) | Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe | |
| AR020836A1 (es) | Vacunas | |
| FR2741806B1 (fr) | Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline | |
| ATE517184T1 (de) | Hcv ns3/4a kodierende nukleinsäure | |
| BR9704879A (pt) | Composição de vacina e uso de um vírus cav vivo | |
| DK1272652T3 (da) | Herpesvirus til immunmodulation | |
| DE60239753D1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
| WO2001070932A3 (en) | Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife | |
| ATE442857T1 (de) | Vakzine zusammensetzung zur impfung von hunden gegen infektiöse atemwegserkrankung bei hunden (cird) | |
| WO2001010469A3 (en) | Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines | |
| PT778894E (pt) | Vacina da peritonite infecciosa felina. | |
| DK1227840T3 (da) | Adjuverede, genetiske vacciner | |
| AU2003278603A8 (en) | Hm1.24-utilizing cancer vaccines | |
| BR0013574A (pt) | Antìgeno vacina de moraxella | |
| AR031599A1 (es) | Vacunas para el virus herpes equino tipo 1: virus que hospeda mutaciones dentro del gen inmediato precoz | |
| HU9900534D0 (en) | Aviadenovirus |